ONCOLOGY SALES EXPANSION: 49 Oncology Account Managers

We suggest using JobsAI to ensure your resume is optimized for the application.

Try JobsAI for FREE

Headline cities

• Atlanta, GA
• Baltimore, MD
• Birmingham, AL
• Boston, MA
• Chicago, IL
• Cincinnati, OH
• Cleveland, OH
• Columbia, SC
• Dallas, TX
• Denver, CO
• Detroit, MI
• Grand Rapids, MI
• Hartford, CT
• Houston, TX
• Indianapolis, IN
• Riverside, CA (Inland Empire)
• Jacksonville, FL
• Jersey City, NJ
• Little Rock, AR
• Los Angeles, CA
• Louisville, KY
• Manhattan, NY (North)
• Brooklyn, NY (Manhattan S./Brooklyn)
• Miami, FL
• Milwaukee, WI
• Minneapolis, MN
• Nashville, TN
• New Orleans, LA
• Oklahoma City, OK
• Omaha, NE
• Orange, CA
• Orlando, FL
• Philadelphia, PA
• Phoenix, AZ (North)
• Phoenix, AZ (South)
• Pittsburgh, PA
• Portland, OR
• Raleigh, NC
• Sacramento, CA
• Salt Lake City, UT
• San Antonio, TX
• San Diego, CA
• San Francisco, CA
• Santa Barbara, CA
• Seattle, WA
• St. Louis, MO
• Syracuse, NY
• Tampa, FL
• Washington, DC

Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators.

In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome).

Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation.

What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.

We are seeking Oncology Account Managers to lead the launch of our first oncology product. This is a unique opportunity to be part of a pioneering team introducing a novel treatment in the oncology space.

The Oncology Account Manager will be responsible for driving awareness, adoption, and demand for Corcept’s entry into the oncology commercial market. You will build and maintain strong relationships with oncologists, key opinion leaders (KOLs), and healthcare providers while executing a strategic sales plan that aligns with corporate goals.

Responsibilities:

• Primary responsibility is to achieve sales goals and ensure high quality interactions with each customer while navigating diverse account dynamics which influence patient access
• Execute account-based plans that bring solutions to HCPs, care teams, and decision makers at cancer centers that enable productive education on the product’s clinical benefits, safety profile, and appropriate patient selection
• Collaborate with cross-functional partners, including marketing, medical affairs, and market access, while consistently applying compliant communication to optimize product positioning and reimbursement strategies
• Contribute to a positive, high-performing culture through continuous self-development, a willingness to challenge the status quo, and a strong sense of accountability, integrity, and grit
• Conduct regular assessments of market dynamics, competitive landscape, and access barriers to identify opportunities and challenges
• Ensure compliance with all laws, regulations and policies that govern the conduct of all activities
• Be a valued member of the Oncology community by representing the company at national and regional oncology Congresses, and industry events
• Ensure our actions align with Corcept ethics and patient-first principles through collaboration, embracing possibilities, following the data, and leading by doing

Preferred Skills, Qualifications and Technical Proficiencies:

• Proven track record of successful product launches and driving sales growth in a competitive oncology market
• Established relationships with medical oncologists, gynecologic oncologists, and cancer centers within the assigned region
• Possess deep knowledge of geography-specific drivers, including oncology treatment pathways, local market dynamics, and the reimbursement landscape
• Strong business acumen with the ability to analyze data and develop strategic action plans
• Ability to work independently and cross-functionally in a fast-paced, entrepreneurial launch environment
• Willingness to travel 50-75% within the territory

Preferred Education and Experience:

• Bachelor’s degree in a relevant field (Life Sciences, Business, or related discipline)
• 10 years’ industry sales experience with a minimum of 5+ years focused on oncology sales with a strong preference for experience in gynecologic oncology and/or ovarian cancer, or related oncology subspecialties
• Experience launching a new oncology product in a start-up or growth-stage pharmaceutical company

The pay range that the Company reasonably expects to pay for this position is $184,000 - $215,000; the pay ultimately offered may vary based on legitimate considerations, including geographic location, job-related knowledge, skills, experience, and education.

 Applicants must be currently authorized to work in the United States on a full-time basis.